{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:15:35Z","timestamp":1785842135759,"version":"3.56.0"},"reference-count":39,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2017,3,15]]},"DOI":"10.1002\/ijc.30537","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T07:36:44Z","timestamp":1480577804000},"page":"1396-1404","source":"Crossref","is-referenced-by-count":56,"title":["Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas"],"prefix":"10.1002","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-4282","authenticated-orcid":false,"given":"Nathaniel L.","family":"Jones","sequence":"first","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital; New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Xiu","sequence":"additional","affiliation":[{"name":"Caris Life Sciences; New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeshna","family":"Chatterjee-Paer","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital; New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Buckley de Meritens","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital; New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Burke","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital; New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Tergas","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital; New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital; New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Y.","family":"Hou","sequence":"additional","affiliation":[{"name":"Columbia University College of Physicians and Surgeons and New York Presbyterian Hospital; New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"10.1002\/ijc.30537-BIB0001|ijc30537-cit-0001","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: Cancer J Clin"},{"key":"10.1002\/ijc.30537-BIB0002|ijc30537-cit-0002","first-page":"228","article-title":"A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses","volume":"81","author":"Lax","year":"1997","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1002\/ijc.30537-BIB0003|ijc30537-cit-0003","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1002\/ijc.30537-BIB0004|ijc30537-cit-0004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1002\/ijc.30537-BIB0005|ijc30537-cit-0005","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ygyno.2015.06.034","article-title":"Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma","volume":"138","author":"Jones","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1002\/ijc.30537-BIB0006|ijc30537-cit-0006","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<814::AID-CNCR12>3.0.CO;2-U","article-title":"The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways","volume":"88","author":"Lax","year":"2000","journal-title":"Cancer"},{"key":"10.1002\/ijc.30537-BIB0007|ijc30537-cit-0007","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cdp.2003.09.005","article-title":"Molecular and histopathologic predictors of distant failure in endometrial cancer","volume":"27","author":"Mariani","year":"2003","journal-title":"Cancer Detect Prevent"},{"key":"10.1002\/ijc.30537-BIB0008|ijc30537-cit-0008","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/ijc.30537-BIB0009|ijc30537-cit-0009","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.2013.35","article-title":"The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium","volume":"26","author":"Fadare","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1002\/ijc.30537-BIB0010|ijc30537-cit-0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0090-8258(03)00264-6","article-title":"Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma","volume":"90","author":"Gemignani","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1002\/ijc.30537-BIB0011|ijc30537-cit-0011","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/PGP.0b013e31828cb0be","article-title":"Primary squamous cell carcinoma of the endometrium: clinicopathologic and molecular characteristics","volume":"32","author":"Bures","year":"2013","journal-title":"Int J Gynecol Pathol"},{"key":"10.1002\/ijc.30537-BIB0012|ijc30537-cit-0012","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.anndiagpath.2005.09.001","article-title":"p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium","volume":"10","author":"Horn","year":"2006","journal-title":"Ann Diagn Pathol"},{"key":"10.1002\/ijc.30537-BIB0013|ijc30537-cit-0013","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1002\/ijc.30537-BIB0014|ijc30537-cit-0014","first-page":"6423","article-title":"Intracellular localization of human DNA repair enzyme methylguanine-DNA methyltransferase by antibodies and its importance","volume":"52","author":"Ayi","year":"1992","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.30537-BIB0015|ijc30537-cit-0015","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum resistance: the role of DNA repair pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.30537-BIB0016|ijc30537-cit-0016","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/emm.2006.38","article-title":"Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer","volume":"38","author":"Kang","year":"2006","journal-title":"Exp Mol Med"},{"key":"10.1002\/ijc.30537-BIB0017|ijc30537-cit-0017","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/jnci\/84.19.1512","article-title":"ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients","volume":"84","author":"Dabholkar","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.30537-BIB0018|ijc30537-cit-0018","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1002\/ijc.30537-BIB0019|ijc30537-cit-0019","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/2159-8290.CD-11-0039","article-title":"High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability","volume":"1","author":"Cheung","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1002\/ijc.30537-BIB0020|ijc30537-cit-0020","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1158\/1078-0432.CCR-06-1375","article-title":"PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia","volume":"12","author":"Hayes","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.30537-BIB0021|ijc30537-cit-0021","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2011.208","article-title":"Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing","volume":"25","author":"Djordjevic","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1002\/ijc.30537-BIB0022|ijc30537-cit-0022","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/bjc.2013.455","article-title":"Loss of PTEN expression is an independent predictor of favourable survival in endometrial carcinomas","volume":"109","author":"Akiyama-Abe","year":"2013","journal-title":"British Journal of Cancer"},{"key":"10.1002\/ijc.30537-BIB0023|ijc30537-cit-0023","doi-asserted-by":"crossref","first-page":"162363","DOI":"10.1155\/2010\/162363","article-title":"Molecular profiling of endometrial malignancies","author":"Samarnthai","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"10.1002\/ijc.30537-BIB0024|ijc30537-cit-0024","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bjc.6605109","article-title":"The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas","volume":"101","author":"Shoji","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1002\/ijc.30537-BIB0025|ijc30537-cit-0025","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.3747\/co.19.1149","article-title":"Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS","volume":"19","author":"Vincent","year":"2012","journal-title":"Curr Oncol"},{"key":"10.1002\/ijc.30537-BIB0026|ijc30537-cit-0026","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/1535-7163.MCT-10-0991","article-title":"Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors","volume":"10","author":"Xia","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/ijc.30537-BIB0027|ijc30537-cit-0027","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.30537-BIB0028|ijc30537-cit-0028","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.30537-BIB0029|ijc30537-cit-0029","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.30537-BIB0030|ijc30537-cit-0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35077219","article-title":"The Hedgehog and Wnt signalling pathways in cancer","volume":"411","author":"Taipale","year":"2001","journal-title":"Nature"},{"key":"10.1002\/ijc.30537-BIB0031|ijc30537-cit-0031","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1101\/gad.1051603","article-title":"Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis","volume":"17","author":"Gunther","year":"2003","journal-title":"Genes Dev"},{"key":"10.1002\/ijc.30537-BIB0032|ijc30537-cit-0032","first-page":"204","article-title":"Biomarkers that currently affect clinical practice in lung cancer: EGFR, ALK, MET, ROS-1, and KRAS","author":"Korpanty","year":"2014","journal-title":"Front Oncol"},{"key":"10.1002\/ijc.30537-BIB0033|ijc30537-cit-0033","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/PAS.0b013e318247b7bb","article-title":"Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?","volume":"36","author":"Alvarez","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1002\/ijc.30537-BIB0034|ijc30537-cit-0034","doi-asserted-by":"crossref","first-page":"e18066","DOI":"10.1371\/journal.pone.0018066","article-title":"Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma","volume":"6","author":"Mhawech-Fauceglia","year":"2011","journal-title":"PLoS One"},{"key":"10.1002\/ijc.30537-BIB0035|ijc30537-cit-0035","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2013.03.011","article-title":"Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas","volume":"129","author":"Ayeni","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1002\/ijc.30537-BIB0036|ijc30537-cit-0036","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/cncr.20645","article-title":"Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?","volume":"101","author":"Boruta","year":"2004","journal-title":"Cancer"},{"key":"10.1002\/ijc.30537-BIB0037|ijc30537-cit-0037","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1525-1438.2002.01151.x","article-title":"Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas","volume":"12","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1002\/ijc.30537-BIB0038|ijc30537-cit-0038","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ygyno.2015.03.041","article-title":"Uterine carcinosarcoma: a review of the literature","volume":"137","author":"Cantrell","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1002\/ijc.30537-BIB0039|ijc30537-cit-0039","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.30537","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ijc.30537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T23:44:10Z","timestamp":1749771850000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.30537"}},"subtitle":["Molecular landscape of endometrial carcinomas"],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,3,15]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.30537","archive":["Portico"],"relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}